Gamidor to sell Tm Bioscience gene tests in Israel:
This article was originally published in Clinica
The well-established Israeli genetic test market is to open to Toronto, Canada-based Tm Bioscience, through a deal with local firm Gamidor Diagnostics. The Petach Tikva-based distributor, which already sells clinical diagnostics for international companies such as Dade Behring and Perkin Elmer Life Sciences, expects Tm's test for cystic fibrosis and its Ashkenazi Jewish panel to be particularly well received.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.